Table 3.
Descriptive health care resource utilization results by cancer site and Eastern Cooperative Oncology Group (ECOG) across performance status (PS) score periods.
| Colorectal cancer |
Lung cancer |
Gastric cancer |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PS 0/1 | PS 2 | PS 3 | PS 4 | PS 0/1 | PS 2 | PS 3 | PS 4 | PS 0/1 | PS 2 | PS 3 | PS 4 | |
| Number of patients | 742 | 108 | 35 | 6 | 421 | 136 | 47 | 2 | 40 | 8 | 3 | 1 |
| Number of PS periods | 1146 | 151 | 39 | 6 | 607 | 136 | 54 | 2 | 73 | 8 | 3 | 1 |
| Duration of time period, mean days (SD) | 308.4 (399.8) | 175.8 (271.7) | 133.6 (254.3) | 204 (248.4) | 251.1 (307.7) | 156.4 (242.3) | 78.6 (124.0) | 17.5 (4.9) | 224.1 (270.8) | 90.5 (141.8) | 260.0 (258.3) | 71.0 (–) |
| Periods with ≥ 1 hospitalization, N (%) | 217 (18.9%) | 36 (23.8%) | 5 (12.8%) | 4 (66.7%) | 131 (21.6%) | 56 (33.3%) | 13 (24.1%) | 0 (0.0%) | 17 (23.3%) | 5 (35.7%) | 1 (33.3%) | 0 (0.0%) |
| Periods with ≥ 1 emergency room (ER) visit, n (%) | 233 (20.3%) | 38 (25.2%) | 8 (20.5%) | 2 (33.3%) | 170 (28.0%) | 51 (30.4%) | 14 (25.9%) | 0 (0.0%) | 15 (20.5%) | 3 (21.4%) | 0 (0.0%) | 1 (100.0%) |
| ER visits per montha, mean (SD) | 0.3 (0.4) | 0.4 (0.4) | 0.6 (0.4) | 0.1 (0.0) | 0.3 (0.3) | 0.6 (0.6) | 0.8 (0.7) | 0.0 (0.0) | 0.5 (0.4) | 0.1 (0.0) | 0.0 (0.0) | 0.8 (–) |
| Periods with systemic anti-cancer therapy administration, n (%) | 402 (35.1%) | 65 (43.%) | 11 (28.2%) | 1 (16.7%) | 225 (37.1%) | 74 (44.0%) | 10 (18.5%) | 0 (0.0%) | 38 (52.1%) | 9 (64.3%) | 0 (0.0%) | 0 (0.0%) |
| Percentage of period receiving systemic anti-cancer therapy, mean (SD) | 55.6% (35.3%) | 66.0% (33.2) | 76.6% (19.8) | 9.5% (–) | 57.8% (30.9) | 55.8% (32.9) | 63.8% (31.5) | 0.0% (0.0) | 64.3% (35.1) | 71.6% (32.2) | 0.0% (0.0) | 0.0% (0.0) |
| Periods with radiation therapy, n (%) | 39 (3.4%) | 6 (4.0%) | 2 (5.1%) | 0 (0.0%) | 95 (15.7%) | 33 (19.6%) | 10 (18.5%) | 1 (50.0%) | 5 (6.8%) | 3 (21.4%) | 1 (33.3%) | 0 (0.0%) |
| Periods with home health care, n (%) | 59 (5.1%) | 13 (8.6%) | 2 (5.1%) | 3 (50.0%) | 12 (2.0%) | 2 (1.2%) | 1 (1.9%) | 0 (0.0%) | 2 (2.7%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Periods with claims for durable medical equipment (DME), n (%) | 456 (39.8%) | 61 (40.4%) | 16 (41.0%) | 3 (50.0%) | 213 (35.1%) | 70 (41.7%) | 22 (40.7%) | 0 (0.0%) | 23 (31.5%) | 5 (35.7%) | 1 (33.3%) | 1 (100.0%) |
| Number of DME claims per montha, mean (SD) | 13.8 (46.7) | 14.3 (35.1) | 10.5 (14.0) | 41 (63.3) | 9.3 (11.7) | 9.8 (15.7) | 5.7 (6.6) | 0.0 (0.0) | 7.6 (10.1) | 9.8 (5.2) | 10 (–) | 2 (–) |
| Periods with anti-emetic use, n (%) | 458 (40.0%) | 64 (42.4%) | 15 (38.5%) | 3 (50.0%) | 275 (45.3%) | 84 (50.0%) | 16 (29.6%) | 0 (0.0%) | 32 (43.8%) | 9 (64.3%) | 2 (66.7%) | 1 (100.0%) |
| Periods with hematopoietic agent use, n (%) | 155 (13.5%) | 44 (29.1%) | 9 (23.1%) | 1 (16.7%) | 98 (16.1%) | 32 (19.0%) | 3 (5.6%) | 0 (0.0%) | 17 (23.3%) | 4 (28.6%) | 0 (0.0%) | 0 (0.0%) |
| Periods with transfusions, n (%) | 16 (1.4%) | 4 (2.6%) | 3 (7.7%) | 0 (0.0%) | 26 (4.3%) | 13 (7.7%) | 5 (9.3%) | 0 (0.0%) | 1 (1.4%) | 1 (7.1%) | 0 (0.0%) | 0 (0.0%) |
Abbreviations. SD, standard deviation.
aAmong those utilizing the resource.